viewRyah Medtech Inc

RYAH Medtech forges research partnership with top Pharma and Oncology player

The new study will include precision dosing and pave the way for the clinic to track how patients are responding to treatments.

Ryah Medtech Inc -
The Ryah vaporizer stores results from vaping sessions to create a picture for patients of how vaping works for them

RYAH Medtech Inc, the medical cannabis and data company, has cemented a deal with a leading pharmaceutical clinic to kick off a research program that will use its dose-measuring vaporizers and dry herb cartridges. 

Under the deal’s terms, the undisclosed oncology clinic will analyze the safety of using cannabis and hemp to treat patients in chronic pain, using RYAH’s proprietary devices which allow medical cannabis patients to precisely control dosage and temperature. The clinic has agreed to purchase about 100,000 RYAH dose-measuring dry herb vaporizers and several million dry herb cartridges over five years, starting in December.

“[By] using our best-in-class vaporizers, cartridges and customized software capabilities, the Clinic will capture medically-relevant seed-to-consumption data on its cannabis-based treatments, which will then be analyzed to assess the safety and efficacy of medical cannabis, with the goal of advancing evidence-based policy making,” said Gregory Wagner, RYAH’s CEO.

READ: RYAH MedTech signs distribution agreement with Australian medical cannabis producer Cannatrek

The new study will include precision dosing and also pave the way for the clinic to track how patients are responding to treatments, with the help of RYAH’s tech.

RYAH, which is headquartered in New York City, will be introducing a customized mobile application and a bit of back-end software for the trial – which will be designed to control temperatures and dosing with precision and direct patient feedback to the clinic.

RYAH uses cartridges pre-filled with either dry herb or concentrate. Users simply scan the cartridge’s QR code, set their parameters and RYAH tracks exactly how much vapor has been inhaled.

The Ryah vaporizer is capable of storing results from vaping sessions to create a picture for doctors and patients of how vaping is working for them and what tweaks — such as cannabis strain, dosage level, frequency or temperature — may need to be made.

“Our vaporizers are smart devices that allow patients to set limits on how much they inhale, track their usage in real time, record how they feel after each session and review their stats over time,” explains Jordan Medley, RYAH’s director of product operations.

News of RYAH’s latest tie-up comes on the heels of its move to set up shop Down Under by striking a distribution agreement with Cannatrek Medical Pty Ltd, a licensed medical cannabis company in Australia.

The deal will see RYAH provide its signature dose-measuring dry herb vaporizers and cartridges to Cannatrek, which will fill them with its proprietary strains and distribute them to patients. 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ryah Medtech Inc named herein, including the promotion by the Company of Ryah Medtech Inc in any Content on the Site, the Company receives from...


RYAH Medtech stocks the shelves with its cannabis vaporizer at Maryland...

RYAH Medtech Inc Head of Marketing and Communications Sofiya Kleschuk and Director of Product Operations Jordan Medley join Maryland Sweetspot Dispensary Manager Peter Franklin to tell Proactive Investors the two have joined forces to begin offering RYAH vaporizers to medical...

on 07/11/2019

2 min read